Addex Therapeutics Ltd. (ADXN)

CIK 1574232 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Addex Therapeutics Ltd..

Recent SEC filings

FiledFormAccession number
Sep 4, 202640001104659-26-105501
Sep 4, 202640001104659-26-105489
Sep 4, 202640001104659-26-105481
Sep 4, 202640001104659-26-105491
Sep 4, 202640001104659-26-105484
Sep 4, 202640001104659-26-105506
Sep 4, 2026SCHEDULE 13D/A0001104659-26-105480
Sep 4, 202640001104659-26-105509
Sep 4, 202640001104659-26-105496
Aug 27, 2026SCHEDULE 13D/A0001104659-26-101798
Aug 26, 20266-K0001171843-26-005744
Jul 8, 20266-K0001171843-26-004524
Jun 30, 20266-K0001171843-26-004375
Jun 25, 20266-K0001104659-26-077470
Jun 5, 20266-K0001171843-26-003926
May 15, 202620-F0001104659-26-062447
Apr 30, 20266-K0001171843-26-002871
Apr 30, 2026NT 20-F0001104659-26-052854
Apr 29, 20266-K0001171843-26-002787
Apr 23, 20266-K0001171843-26-002661
Apr 21, 20266-K0001171843-26-002589
Mar 25, 202630001104659-26-034491
Mar 25, 202630001104659-26-034498
Mar 25, 202630001104659-26-034503
Mar 25, 202630001104659-26-034501